Hot Topics of Discussion US FDA panel votes against Amylyx’s ALS drug over trial data concerns Date: March 30, 2022Author: 0 Comments 0 0 Advertisements Read Time:0 Second Post Content Share Facebook Twitter Pinterest LinkedIn About Post Author Happy 0 0 % Sad 0 0 % Excited 0 0 % Sleepy 0 0 % Angry 0 0 % Surprise 0 0 % Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Share on Reddit (Opens in new window) Reddit Share on Tumblr (Opens in new window) Tumblr Share on Pinterest (Opens in new window) Pinterest FDA Panel Narrowly Sides Against Experimental ALS DrugDateMarch 30, 2022In relation toSimilar postALS Drug Gets Rare Second Review at High-Stakes FDA MeetingDateSeptember 7, 2022In relation toSimilar postFDA Skeptical of Benefits From Experimental ALS DrugDateMarch 28, 2022In relation toSimilar post